Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Serge Maeder

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Chemical Research in Toxicology|May 21, 2025
A Comparative Assessment of the FDA List of 93 HPHCs in Aerosol Generated by Tobacco Heating System 2.2 versus 3R4F Reference Cigarette SmokeSerge Maeder, Cyril Jeannet
Internal and Emergency Medicine|February 16, 2019
Assessing the lung cancer risk reduction potential of candidate modified risk tobacco productsJulia Hoeng, Serge Maeder, Patrick Vanscheeuwijck, et al.
Analytical and Bioanalytical Chemistry|January 13, 2024
Non-targeted analytical comparison of a heated tobacco product aerosol against mainstream cigarette smoke: does heating tobacco produce an inherently different set of aerosol constituents?Gerhard Lang, Carlos Henao, Martin Almstetter, et al.
Analytical and Bioanalytical Chemistry|February 20, 2020
Comprehensive chemical characterization of the aerosol generated by a heated tobacco product by untargeted screeningMark C Bentley, Martin Almstetter, Daniel Arndt, et al.
Regulatory Toxicology and Pharmacology : RTP|June 18, 2016
Comparison of the impact of the Tobacco Heating System 2.2 and a cigarette on indoor air qualityMaya I Mitova, Pedro B Campelos, Catherine G Goujon-Ginglinger, et al.
Toxicology Reports|September 30, 2020
Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use caseWalter K Schlage, Bjoern Titz, Anita Iskandar, et al.
Regulatory Toxicology and Pharmacology : RTP|October 11, 2016
Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosolJean-Pierre Schaller, Daniela Keller, Laurent Poget, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Chemical Research in Toxicology|May 21, 2025
A Comparative Assessment of the FDA List of 93 HPHCs in Aerosol Generated by Tobacco Heating System 2.2 versus 3R4F Reference Cigarette SmokeSerge Maeder, Cyril Jeannet
Internal and Emergency Medicine|February 16, 2019
Assessing the lung cancer risk reduction potential of candidate modified risk tobacco productsJulia Hoeng, Serge Maeder, Patrick Vanscheeuwijck, et al.
Analytical and Bioanalytical Chemistry|January 13, 2024
Non-targeted analytical comparison of a heated tobacco product aerosol against mainstream cigarette smoke: does heating tobacco produce an inherently different set of aerosol constituents?Gerhard Lang, Carlos Henao, Martin Almstetter, et al.
Analytical and Bioanalytical Chemistry|February 20, 2020
Comprehensive chemical characterization of the aerosol generated by a heated tobacco product by untargeted screeningMark C Bentley, Martin Almstetter, Daniel Arndt, et al.
Regulatory Toxicology and Pharmacology : RTP|June 18, 2016
Comparison of the impact of the Tobacco Heating System 2.2 and a cigarette on indoor air qualityMaya I Mitova, Pedro B Campelos, Catherine G Goujon-Ginglinger, et al.
Toxicology Reports|September 30, 2020
Comparing the preclinical risk profile of inhalable candidate and potential candidate modified risk tobacco products: A bridging use caseWalter K Schlage, Bjoern Titz, Anita Iskandar, et al.
Regulatory Toxicology and Pharmacology : RTP|October 11, 2016
Evaluation of the Tobacco Heating System 2.2. Part 2: Chemical composition, genotoxicity, cytotoxicity, and physical properties of the aerosolJean-Pierre Schaller, Daniela Keller, Laurent Poget, et al.
Pageof 1